Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:Robinul
|
| gptkbp:brand |
gptkb:Robinul_Forte
gptkb:Robinul |
| gptkbp:category |
Category C
|
| gptkbp:class |
Anticholinergic agent
|
| gptkbp:clinical_trial |
Used in anesthesia
Used in dentistry Used in gastroenterology Used in palliative care Various clinical trials |
| gptkbp:contraindication |
gptkb:Myasthenia_gravis
Glaucoma Urinary retention |
| gptkbp:dosage_form |
gptkb:tablet
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:excretion |
Renal
|
| gptkbp:formulation |
Oral tablet
1 mg 2 mg |
| gptkbp:frequency |
As directed by physician
|
| https://www.w3.org/2000/01/rdf-schema#label |
Robinul Forte
|
| gptkbp:indication |
Preoperative use
|
| gptkbp:ingredients |
gptkb:Glycopyrrolate
|
| gptkbp:interacts_with |
Antihistamines
Other anticholinergics Tricyclic antidepressants May increase effects of other medications |
| gptkbp:is_available_on |
Generic version
|
| gptkbp:is_used_for |
Reducing saliva production
|
| gptkbp:lifespan |
1.5 to 2 hours
|
| gptkbp:manager |
Oral
|
| gptkbp:manufacturer |
Various manufacturers
|
| gptkbp:metabolism |
Hepatic
|
| gptkbp:packaging |
Blister pack
|
| gptkbp:population |
Consult healthcare provider
|
| gptkbp:provides_information_on |
Follow prescribing information
|
| gptkbp:scholarships |
Avoid alcohol
Avoid driving if drowsy Report severe side effects |
| gptkbp:side_effect |
Dizziness
Constipation Blurred vision Dry mouth |
| gptkbp:storage |
Room temperature
|
| gptkbp:symptoms |
gptkb:Fever
Confusion Flushing Rapid heart rate |
| gptkbp:treatment |
Supportive care for overdose
|